Literature DB >> 17564709

Letter to the editor. Re: Specificity of anti-centromere antibodies for scleroderma.

P Roberts-Thomson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17564709     DOI： 10.1007/s00296-007-0390-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  9 in total

Review 1.  Criteria for the classification of early systemic sclerosis.

Authors:  E C LeRoy; T A Medsger
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

Review 2.  Antinuclear antibody testing in a regional immunopathology laboratory.

Authors:  Peter J Roberts-Thomson; Tony Nikoloutsopoulos; Sally Cox; Jennifer G Walker; Tom P Gordon
Journal:  Immunol Cell Biol       Date:  2003-10       Impact factor: 5.126

3.  A proposal of criteria for the classification of systemic sclerosis.

Authors:  Oleg Nadashkevich; Paul Davis; Marvin J Fritzler
Journal:  Med Sci Monit       Date:  2004-10-26

4.  Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies.

Authors:  John D Reveille; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2003-06-15

5.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

Authors:  L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-03

6.  Incidence and clinical correlation of anticentromere antibody in Thai patients.

Authors:  Krisaree Pakunpanya; Oravan Verasertniyom; Monchand Vanichapuntu; Prapaporn Pisitkun; Kitti Totemchokchyakarn; Kanokrat Nantiruj; Suchela Janwityanujit
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

7.  Clinical and serological heterogeneity in patients with anticentromere antibodies.

Authors:  Shoji Miyawaki; Hiroko Asanuma; Susumu Nishiyama; Yasuhiko Yoshinaga
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

8.  A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients.

Authors:  H Rand Maricq; I Valter
Journal:  Clin Exp Rheumatol       Date:  2004 Jan-Feb       Impact factor: 4.473

9.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.